Anika Therapeutics (ANIK) Work In Process (2011 - 2018)

Anika Therapeutics (ANIK) has reported Work In Process for 8 consecutive years, with $5.9 million the latest figure, recorded in Q3 2018.

• On a quarterly basis, Work In Process fell 9.38% year-over-year to $5.9 million in Q3 2018; TTM through Sep 2018 was $5.9 million, a 9.38% decrease from a year earlier, with the FY2017 full-year figure at $6.1 million, up 9.05% from the prior year.
• Work In Process was $5.9 million for Q3 2018 at Anika Therapeutics, down from $6.3 million in the prior quarter.
• Over five years, Work In Process peaked at $6.6 million in Q3 2017 and troughed at $2.2 million in Q2 2014.
• A 5-year average of $4.8 million and a median of $5.6 million in 2016 frame the typical range for Work In Process.
• Across the five-year window, Work In Process jumped 94.43% in 2016 and declined 9.38% in 2018, its largest moves.
• Over 5 years, Work In Process stood at $3.0 million in 2014, then surged by 85.99% to $5.7 million in 2015, then fell by 1.71% to $5.6 million in 2016, then grew by 9.05% to $6.1 million in 2017, then slipped by 1.88% to $5.9 million in 2018.
• The last three Work In Process figures came in at $5.9 million (Q3 2018), $6.3 million (Q2 2018), and $5.9 million (Q1 2018), per Business Quant data.